Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 73.84% is in line with its 5-year average of 77.03%, near the high end of its 5-year range (49.38%–82.74%).
10.10% above its 12-month average of 67.07%.
Reported quarterly gross margin; no daily interpolation.
GROSS MARGIN
73.84%
GROSS MARGIN AVG TTM
67.07%
GROSS MARGIN AVG 3Y
77.19%
GROSS MARGIN AVG 5Y
77.03%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+10.10%
CURRENT VS 3Y AVG
-4.34%
CURRENT VS 5Y AVG
-4.14%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
58.99%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
+25.16%
vs the sector median at left
Hims & Hers Health, Inc.
Market Cap
$6.28B
Gross Margin
73.84%
TTM Avg
67.07%
3Y Avg
77.19%
5Y Avg
77.03%
Market Cap
$6.88B
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
-67.67%
5Y Avg
-188.00%
Market Cap
$5.22B
Gross Margin
49.52%
TTM Avg
48.04%
3Y Avg
46.91%
5Y Avg
45.73%
Market Cap
$8.56B
Gross Margin
14.38%
TTM Avg
17.24%
3Y Avg
38.82%
5Y Avg
59.22%
Market Cap
$3.05B
Gross Margin
58.69%
TTM Avg
59.64%
3Y Avg
63.22%
5Y Avg
64.62%
Market Cap
$9.94B
Gross Margin
14.14%
TTM Avg
15.74%
3Y Avg
16.11%
5Y Avg
16.54%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Hims & Hers Health, Inc. (HIMS) | $6.28B | 73.84% | 67.07% | 77.19% | 77.03% |
| Chemed Corporation (CHE)vs › | $6.78B | 30.44% | 32.55% | 34.06% | 34.32% |
| Scholar Rock Holding Corporation (SRRK)vs › | $6.88B | 0.00% | 0.00% | -67.67% | -188.00% |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.22B | 49.52% | 48.04% | 46.91% | 45.73% |
| Doximity, Inc. (DOCS)vs › | $4.57B | 88.07% | 89.65% | 88.97% | 88.20% |
| Oscar Health, Inc. (OSCR)vs › | $8.56B | 14.38% | 17.24% | 38.82% | 59.22% |
| TransMedics Group, Inc. (TMDX)vs › | $3.05B | 58.69% | 59.64% | 63.22% | 64.62% |
| Insulet Corp. (PODD)vs › | $9.85B | 71.08% | 70.71% | 67.87% | 67.39% |
| The Ensign Group, Inc. (ENSG)vs › | $9.94B | 14.14% | 15.74% | 16.11% | 16.54% |
| Globus Medical, Inc. (GMED)vs › | $10.12B | 68.55% | 63.16% | 66.39% | 68.84% |
Gross Margin
73.8%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 63.83% |
| 2026-03-31 | 49.38% |
| 2025-12-31 | 71.94% |
| 2025-09-30 | 73.80% |
| 2025-06-30 | 76.39% |
| 2025-03-31 | 73.50% |
| 2024-12-31 | 76.81% |
| 2024-09-30 | 79.16% |
| 2024-06-30 | 81.30% |
| 2024-03-31 | 82.36% |
| 2023-12-31 | 82.74% |
| 2023-09-30 | 82.62% |
| 2023-06-30 | 81.84% |
| 2023-03-31 | 80.42% |
| 2022-12-31 | 79.15% |
| 2022-09-30 | 79.02% |
| 2022-06-30 | 76.76% |
| 2022-03-31 | 73.79% |
| 2021-12-31 | 73.32% |
| 2021-09-30 | 73.98% |
| 2021-06-30 | 77.90% |
| 2021-03-31 | 76.93% |
| 2020-12-31 | 76.91% |
| 2020-09-30 | 75.69% |
| 2020-06-30 | 71.47% |
| 2020-03-31 | 68.59% |
| 2019-12-31 | 61.09% |
| 2019-09-30 | 56.49% |
| 2019-06-30 | 47.71% |
| 2019-03-31 | 47.71% |
